STERIS (STE) PT Lowered to $248 at Needham & Company
Needham & Company analyst Mike Matson lowered the price target on STERIS (NYSE: STE) to $248.00 (from $263.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
